This subsequently enhances p38 phosphorylation and glycogen synthase kinase 3β (GSK3β), promotes hyperactivation of Wnt4/β-catenin-FOXL2 signaling, and 46, XY DSD. The gene discussed is WNT4; the disease is disorder of sexual differentiation.